This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Salyers WJ, Vega KJ, Munoz JC, Trotman BW, Tanev SS. Neuroendocrine tumors of the gastrointestinal tract: case reports and literature review. World J Gastrointest Oncol. 2014;6(8):301–310.SalyersWJVegaKJMunozJCTrotmanBWTanevSSNeuroendocrine tumors of the gastrointestinal tract: case reports and literature review201468301310Search in Google Scholar
Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist. 2008;13(12):1255–1269.PinchotSNHolenKSippelRSChenHCarcinoid tumors2008131212551269Search in Google Scholar
Rindi G, Klimstra DS, Abedi-Ardekani B, Asa SL, Bosman FT, Brambilla E, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31(12):1770–1864.RindiGKlimstraDSAbedi-ArdekaniBAsaSLBosmanFTBrambillaEA common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal2018311217701864Search in Google Scholar
Ellis L, Shale MJ, Coleman MP. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol. 2010;105(12):2563–2569.EllisLShaleMJColemanMPCarcinoid tumors of the gastrointestinal tract: trends in incidence in England since 197120101051225632569Search in Google Scholar
Altekruse SF, Rosenfeld GE, Carrick DM, Pressman EJ, Schully SD, Mechanic LE, et al. SEER cancer registry biospecimen research: yesterday and tomorrow. Cancer Epidemiol Biomarkers Prev. 2014;23(12):2681–2687.AltekruseSFRosenfeldGECarrickDMPressmanEJSchullySDMechanicLESEER cancer registry biospecimen research: yesterday and tomorrow2014231226812687Search in Google Scholar
Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. The Surveillance, Epidemiology, and End Results (SEER) Program and pathology: toward strengthening the critical relationship. Am J Surg Pathol. 2016;40(12):e94–e102.DugganMAAndersonWFAltekruseSPenberthyLShermanMEThe Surveillance, Epidemiology, and End Results (SEER) Program and pathology: toward strengthening the critical relationship20164012e94e102Search in Google Scholar
Yu JB, Gross CP, Wilson LD, Smith BD. NCI SEER public-use data: applications and limitations in oncology research. Oncology (Williston Park). 2009;23(3):288–295.YuJBGrossCPWilsonLDSmithBDNCI SEER public-use data: applications and limitations in oncology research2009233288295Search in Google Scholar
Scherubl H, Streller B, Stabenow R, Herbst H, Hopfner M, Schwertner C, et al. Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany. World J Gastroenterol. 2013;19(47):9012–9019.ScherublHStrellerBStabenowRHerbstHHopfnerMSchwertnerCClinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany2013194790129019Search in Google Scholar
Pavel M, Oberg K, Falconi M, Krenning EP, Sundin A, Perren A, et al. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(7):844–860.PavelMObergKFalconiMKrenningEPSundinAPerrenAGastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up2020317844860Search in Google Scholar
Scott AT, Howe JR. Management of small bowel neuroendocrine tumors. J Oncol Pract. 2018;14(8):471–482.ScottATHoweJRManagement of small bowel neuroendocrine tumors2018148471482Search in Google Scholar
McCarthy DM. Proton pump inhibitor use, hypergastrinemia, and gastric carcinoids—what is the relationship? Int J Mol Sci. 2020;21(2):662.McCarthyDMProton pump inhibitor use, hypergastrinemia, and gastric carcinoids—what is the relationship?2020212662Search in Google Scholar
Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335–1342.DasariAShenCHalperinDZhaoBZhouSXuYTrends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States201731013351342Search in Google Scholar
Wu L, Fu J, Wan L, Pan J, Lai S, Zhong J, et al. Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study. Oncotarget. 2017;8(3):4935–4947.WuLFuJWanLPanJLaiSZhongJSurvival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study20178349354947Search in Google Scholar
Estrozi B, Bacchi CE. Neuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases. Clinics (Sao Paulo). 2011;66(10):1671–1675.EstroziBBacchiCENeuroendocrine tumors involving the gastroenteropancreatic tract: a clinicopathological evaluation of 773 cases2011661016711675Search in Google Scholar
Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19(12):991–1002.OronskyBMaPCMorgenszternDCarterCANothing but NET: a review of neuroendocrine tumors and carcinomas201719129911002Search in Google Scholar
Nozari N, Nikfam S, Nikmanesh A, Mohammadnejad M, Sotoudehmanesh R, Zamani F, et al. Clinical and pathological features of non-functional neuroendocrine tumors of pancreas: a report from Iran. Middle East J Dig Dis. 2014;6(3):151–155.NozariNNikfamSNikmaneshAMohammadnejadMSotoudehmaneshRZamaniFClinical and pathological features of non-functional neuroendocrine tumors of pancreas: a report from Iran201463151155Search in Google Scholar
Zeng YJ, Liu L, Wu H, Lai W, Cao JZ, Xu HY, et al. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution. Asian Pac J Cancer Prev. 2013;14(10):5775–5781.ZengYJLiuLWuHLaiWCaoJZXuHYClinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution2013141057755781Search in Google Scholar
Maggard MA, O’Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240(1):117–122.MaggardMAO’ConnellJBKoCYUpdated population-based review of carcinoid tumors20042401117122Search in Google Scholar
Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97(4):934–959.ModlinIMLyeKDKiddMA 5-decade analysis of 13,715 carcinoid tumors2003974934959Search in Google Scholar
Quaedvlieg PF, Visser O, Lamers CB, Janssen-Heijen ML, Taal BG. Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Ann Oncol. 2001;12(9):1295–1300.QuaedvliegPFVisserOLamersCBJanssen-HeijenMLTaalBGEpidemiology and survival in patients with carcinoid disease in The Netherlands200112912951300Search in Google Scholar
Gkolfinopoulos S, Tsapakidis K, Papadimitriou K, Papamichael D, Kountourakis P. Chromogranin A as a valid marker in oncology: clinical application or false hopes? World J Methodol. 2017;7(1):9–15.GkolfinopoulosSTsapakidisKPapadimitriouKPapamichaelDKountourakisPChromogranin A as a valid marker in oncology: clinical application or false hopes?201771915Search in Google Scholar
Cesar D, Zanatto RM, da Silva MV, Golcalves R, de Mello EL, de Jesus JP. Colon and rectum neuroendocrine tumors: experience of the National Cancer Institute in Brazil. Arq Bras Cir Dig. 2013;26(1):36–39.CesarDZanattoRMda SilvaMVGolcalvesRde MelloELde JesusJPColon and rectum neuroendocrine tumors: experience of the National Cancer Institute in Brazil20132613639Search in Google Scholar
Sansone A, Lauretta R, Vottari S, Chiefari A, Barnabei A, Romanelli F, et al. Specific and non-specific biomarkers in neuroendocrine gastroenteropancreatic tumors. Cancers (Basel). 2019;11(8):1113.SansoneALaurettaRVottariSChiefariABarnabeiARomanelliFSpecific and non-specific biomarkers in neuroendocrine gastroenteropancreatic tumors20191181113Search in Google Scholar
Tang H, Lu W, Li B, Meng X, Dong J. Influence of surgical margins on overall survival after resection of intrahepatic cholangiocarcinoma: a meta-analysis. Medicine (Baltimore). 2016;95(35):e4621.TangHLuWLiBMengXDongJInfluence of surgical margins on overall survival after resection of intrahepatic cholangiocarcinoma: a meta-analysis20169535e4621Search in Google Scholar
Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241(5):715–22, discussion 22–24.PawlikTMScogginsCRZorziDAbdallaEKAndresAEngCEffect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases2005241571522discussion 22–24.Search in Google Scholar
Habal N, Sims C, Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol. 2000;75(4):310–316.HabalNSimsCBilchikAJGastrointestinal carcinoid tumors and second primary malignancies2000754310316Search in Google Scholar
Dhruv S, Anwar S, Polavarapu A, Liliane D. Gastric carcinoid: the invisible tumor! Cureus. 2021;13(2):e13556.DhruvSAnwarSPolavarapuALilianeDGastric carcinoid: the invisible tumor!2021132e13556Search in Google Scholar